Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
138.23
-4.30 (-3.02%)
At close: May 22, 2026, 4:00 PM EDT
138.32
+0.09 (0.07%)
After-hours: May 22, 2026, 7:02 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $6.74 billion as of May 22, 2026. Its market cap has increased by 1,592.01% in one year.
Market Cap
6.74B
Enterprise Value
6.68B
1-Year Change
1,592.01%
Ranking
Category
Stock Price
$138.23
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $6.74B, an increase of 4,934.33%. That is a compound annual growth rate of 57.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 6.74B | 46.06% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Techne | 7.42B |
| Immunovant | 7.01B |
| Vaxcyte | 6.84B |
| Kymera Therapeutics | 6.63B |
| Protagonist Therapeutics | 6.56B |
| Spyre Therapeutics | 6.45B |
| Corcept Therapeutics | 6.41B |
| Rhythm Pharmaceuticals | 6.18B |